Pembrolizumab

Real-world assessment of response to anti-PD1 therapy in advanced cutaneous squamous cell carcinoma

We provide a real-world assessment of response to anti-PD1 therapy in advanced cutaneous squamous cell carcinoma.

Metastatic Merkel Cell Carcinoma Masquerading as multiple immune-related Adverse Events

We present a case of MCC masquerading as Multiple Immune-Related Adverse Events